2025 fourth_quarter Filing
Q4Income
$20K
Filed
January 20, 2026
Lobbying Activities
Trade (domestic/foreign)View all
Issues relating to the implementation of Section 232 tariffs and reciprocal tariffs on pharmaceutical ingredients.
Contacted:Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR)
Lobbyists (3)
JOSHUA MOREY
mrs DANA SCHNEEBERGER WOOD
JOHN HERMANN